Hydrocortone

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hydrocortone

Quick Facts

Property Description
Active ingredient Hydrocortisone
Form Tablet, Injection, Cream, Ointment, etc.
Pharmacological class Corticosteroid (Glucocorticoid)
General purpose Hormone replacement, Anti-inflammatory
Origin Synthetic equivalent of natural cortisol

What Type of Medicine is Hydrocortone?

Hydrocortone is a prescription pharmaceutical preparation containing the active ingredient hydrocortisone, and is classified primarily as a powerful glucocorticoid within the broader corticosteroid drug class. This substance is chemically and physiologically identical to the body's natural hormone, cortisol, which is secreted by the adrenal glands to manage stress, immune function, and metabolism. The identity of hydrocortisone with cortisol is clinically recognized for its essential role in maintaining homeostasis.

As an adrenocortical steroid, hydrocortisone possesses dual activity, providing significant glucocorticoid effects, which powerfully reduce inflammation, and low-potency mineralocorticoid effects. Hydrocortisone serves as a standard for treating adrenocortical insufficiency.


Composition and General Purpose

The core component is hydrocortisone, a substance structurally defined as an endogenous steroid hormone, although the pharmaceutical version is manufactured through synthetic means. This single active ingredient is prepared in multiple dosage form(s). Hydrocortone is often associated with the oral tablet form, intended for systemic ingestion, although the underlying hydrocortisone substance is available in injectable salts and topical preparations.

The overarching general purpose of Hydrocortone is two-fold: to provide essential replacement therapy when the adrenal glands produce insufficient natural cortisol, and to act as a powerful anti-inflammatory and immunosuppressive agent. Hydrocortisone is classified as an essential medicine for its recognized capacity to manage severe inflammatory and allergic conditions. This means the medicine is widely recognized for its ability to quickly suppress swelling and calm an overactive immune response.

Regulatory References

  1. NIH, Hydrocortisone for Adrenal Insufficiency
  2. World Health Organization (WHO)

What side effects are possible with Hydrocortone?

Hydrocortone (hydrocortisone) is a systemic corticosteroid associated with a range of possible adverse reactions, which are generally related to the dose and duration of therapy. Safety information is defined by official governmental regulatory documentation.

Serious Adverse Reactions

The most serious documented safety concerns include adrenal insufficiency or crisis, particularly when the medication is abruptly stopped or during periods of stress. Hydrocortisone can suppress the immune system, increasing the risk of severe or fatal infections (viral, bacterial, fungal, protozoan), and may mask signs of an existing infection. Other serious risks include gastrointestinal perforation and hemorrhage from peptic ulcer disease, glaucoma or posterior subcapsular cataracts, and the emergence of Cushingoid state.

Key Adverse Reaction Categories

Adverse effects are categorized across multiple body systems, most commonly affecting:

  • Fluid and Electrolytes: Hypertension, sodium and fluid retention, and potassium loss.
  • Musculoskeletal: Muscle weakness, loss of muscle mass, and long-term risks of osteoporosis and bone fractures.
  • Endocrine/Metabolic: Suppression of the hypothalamic-pituitary-adrenal (HPA) axis, decreased carbohydrate tolerance, and manifestations of latent diabetes mellitus.
  • Neurological/Psychiatric: Headache, increased intracranial pressure (pseudotumor cerebri), and psychiatric disturbances ranging from mood swings and insomnia to frank psychotic manifestations.

Population-Specific Considerations

In pediatric patients, prolonged use can cause suppression of growth and development. Infants born to mothers who received substantial doses during pregnancy should be closely monitored for signs of hypoadrenalism. Use in pregnant or nursing women requires careful consideration of the potential risks to the fetus or infant.

The regulatory safety profile mandates that the lowest effective dose be used, and that any reduction in dosage must be gradual to minimize the risk of secondary adrenocortical insufficiency.

Overdose and Emergency Response

Overdose and When to Seek Help

Hydrocortone (hydrocortisone) overdose can present as two primary types of exposure: acute and chronic. Immediate medical attention is required for any suspected overdose.

Acute Overdose Manifestations

Acute overdose, often resulting from taking a large amount in a short time, is generally associated with minor changes in the body's fluid and electrolyte balance. However, the most serious concern for acute overdose involves disturbances to the heart rhythm, which may require immediate medical monitoring and intervention.

Chronic Overdose Risks

Long-term use of Hydrocortone at doses higher than those naturally produced by the body (supra-physiological doses) can lead to a condition resembling Cushing's syndrome. This chronic exposure is linked to serious health risks, including an increased risk of cardiovascular morbidity and mortality, features like hypertension, diabetes, and distinctive changes in body fat distribution. For children and adolescents, chronic overdose is indicated by signs such as excessive weight gain combined with decreased growth rate.

When to Seek Emergency Help

  • Call emergency services (e.g., 911) immediately if the individual has collapsed, is having a seizure, has trouble breathing, or cannot be awakened.
  • Contact a poison control center immediately for guidance in all other suspected overdose situations. Take the medicine container or information with you.

Therapeutic Uses of Hydrocortone

Hydrocortone, a corticosteroid medicine, is used to manage a wide array of conditions, including those involving systemic imbalance and inflammatory states.

The medication is commonly applied across three key therapeutic domains: essential hormone replacement therapy for deficiency conditions like Adrenocortical Insufficiency and Addison's disease; is used for managing severe systemic inflammation in autoimmune diseases such as Rheumatoid Arthritis and Lupus; and applied across domains where additional symptomatic support is needed during acute, critical scenarios like the Acute Adrenal Crisis and severe allergic reactions.

In these contexts, Hydrocortone provides support that helps ease the overall symptom burden by addressing symptom clusters that create noticeable physiological strain, including profound fatigue, debilitating weakness, widespread swelling, and acute pain. It is relevant in clinical settings that involve acute or unstable symptom patterns where temporary assistance in symptom stabilization is important.

“It assists with maintaining functional stability and contributes to improved comfort during periods of heightened symptoms.”


Quick Fact: Relief for Severe Inflammation Hydrocortone is applied in conditions characterized by periods of heightened symptoms to manage severe manifestations of autoimmune and inflammatory bowel diseases (like Crohn’s disease), thereby supporting the patient during difficult episodes by easing distress.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Hydrocortone

The eligibility profile for systemic Hydrocortone is defined by official regulatory documentation, establishing clear restrictions and contraindications based on patient population and pre-existing conditions.

Category Official Regulatory Statement
Populations for whom use is Contraindicated Patients with known Systemic Fungal Infections or confirmed hypersensitivity to the drug or its components. Use is also contraindicated when receiving live virus vaccines (e.g., Measles, Mumps, Rubella).
Age-related Eligibility Rules Adults are generally eligible for use. Pediatric patients require careful monitoring due to the regulatory-documented risk of growth retardation with systemic use. Older adults may require caution due to age-related changes in organ function.
Condition-specific Limitations Conditional use is required for patients with comorbidities like congestive heart failure, hypertension, or renal insufficiency due to the risk of salt and water retention. Caution is also advised in patients with diabetes mellitus as Hydrocortone can elevate blood glucose levels.
Reproductive Eligibility Status Pregnancy requires a careful assessment of potential benefit versus fetal hazard. Breastfeeding mothers are advised against nursing when taking pharmacologic doses due to the excretion of the drug in human milk.

Official regulatory documents establish who can and cannot use Hydrocortone by setting absolute contraindications for infectious and allergic populations and by defining conditional eligibility for patients with specific cardiovascular and metabolic comorbidities.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile of Hydrocortone (hydrocortisone) based on agents that alter its metabolism or compound its systemic effects. The following interactions are documented at a high level by government health authorities.

Formal Interaction Restrictions

Co-administration is officially contraindicated with Live or Live-attenuated Vaccines when hydrocortisone is administered at immunosuppressive doses. Use is also restricted in the presence of Systemic Fungal Infections unless needed to manage a life-threatening drug reaction. Separately, consumption of Grapefruit Juice may increase hydrocortisone plasma levels.

Pharmacokinetic Interactions (Exposure Modification)

Interacting Agent Class Official Interaction Description
Hepatic Enzyme Inducers (CYP3A4) Increase the clearance of hydrocortisone (e.g., Phenytoin, Rifampin), potentially reducing its therapeutic effect (lower exposure).
Hepatic Enzyme Inhibitors (CYP3A4) Decrease the metabolism of hydrocortisone (e.g., Ketoconazole, Itraconazole), expected to increase its serum concentration (higher exposure).

Pharmacodynamic Interactions

Concurrent use with Potassium-Depleting Agents (e.g., specific diuretics) officially enhances the risk of hypokalemia (low potassium). Hydrocortisone may also antagonize the therapeutic effect of Antidiabetic Agents (e.g., insulin) and may alter the anticoagulant effect of Warfarin. Furthermore, the effects of hydrocortisone are officially enhanced in patients with hepatic impairment (cirrhosis) due to decreased metabolism.

Mechanism of Action

Hydrocortone is a glucocorticoid that acts as an agonist for the intracellular glucocorticoid receptor (GR), primarily located in the cytoplasm of target cells. Upon binding, the activated complex translocates into the cell nucleus, where it functions as a transcription factor. This complex then directly modulates the transcription of numerous genes by binding to glucocorticoid response elements ( GREs) or by inhibiting other transcription factors. The key molecular consequence is the altered expression of inflammatory mediators and signaling proteins. Mechanistically, Hydrocortone induces the expression of Annexin A1 (Lipocortin-1), which subsequently inhibits Phospholipase A2 ( PLA2). This inhibition reduces the synthesis of eicosanoids, including prostaglandins and leukotrienes. Furthermore, Hydrocortone suppresses the activity of the transcription factor NF-kappaB, thereby downregulating the expression of pro-inflammatory cytokines and adhesion molecules. This cascade ultimately results in the modulation of cellular responses across various tissues and physiological systems.

Dosage and Administration Information

Administration Guidelines for Hydrocortone

The usage of hydrocortisone, the active ingredient in Hydrocortone, is determined by the specific condition being addressed.

Administration Scope and Routes

Hydrocortone is available in multiple forms, which determine the route of administration:

  • Oral: Tablets or granules are used for chronic therapy. Tablets are typically taken with food or milk to minimise gastrointestinal irritation.
  • Parenteral: Sterile powder for injection is used for intravenous (IV) or intramuscular (IM) administration, typically in acute, urgent settings.
  • Localized: Topical and rectal (enema) preparations are used for localized conditions.

Standard Dosing and Frequency

Usage Context Standard Adult Dosing Frequency Pattern
Chronic Replacement 15 mg to 25 mg total daily dose. Dosing is typically divided (e.g., 2 or 3 times per day), with the largest dose administered in the morning.
Acute/High-Dose Initial doses range from 100 mg to 500 mg IV/IM. The initial high dose may be repeated at intervals of 2, 4, or 6 hours as clinically indicated.

Special Procedural Instructions

Duration and Tapering: High-dose parenteral therapy is typically limited to 48 to 72 hours for acute stabilization. After prolonged use, the medicine must be withdrawn gradually (tapered) to prevent complications.

Preparation: The powder for injection must be reconstituted (mixed with a specified diluent, such as sterile water) before IV or IM use. Oral granules for pediatric use should not be chewed or crushed; they are typically sprinkled onto soft food for immediate consumption.

Pediatric Dosing: Dosage for children is calculated based on body surface area (e.g., mg/ m^2/ day) or body weight and divided into doses.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Hydrocortone


Evidence for Use in Hormone Replacement Therapy (Adrenal Insufficiency)

Research has focused extensively on hydrocortisone in the context of cortisol replacement in conditions involving systemic or functional imbalance, such as Adrenocortical Insufficiency. Studies monitored outcomes related to daily functioning or activity level, including Quality of Life (QoL) scores, and physiological strain. Research utilized Pharmacokinetic (PK) studies and randomized controlled trials (RCTs) comparing different schedules. Data show patterns related to patient-reported symptoms, though some reports indicate that existing oral regimens may lead to blood levels that show variability when compared to the body's natural cycle. The research provides limited insight into the most effective regimen to consistently maintain physiological cortisol concentrations, and the optimal long-term approach for minimizing potential effects on markers like glucose or body weight is still emerging.


Evidence for Use in Acute Systemic Inflammatory Conditions

Hydrocortisone was evaluated in research contexts involving acute or disruptive episodes, particularly in critical care settings like septic shock and severe community-acquired pneumonia. The research used systematic reviews and large randomized controlled trials (RCTs) to examine survival endpoints, such as 28-day mortality, and measures of temporary physiological imbalance, such as time to resolve low blood pressure. Findings demonstrated variability across some of the largest trials examining short-term survival outcomes. Evidence derived from settings with varying symptom burdens indicates that responses may be linked to factors such as the timing of administration. The evidence level for survival outcomes in some acute inflammatory states is designated as low or moderate, reflecting the conflicting findings reported.


Evidence for Use in Chronic Autoimmune and Inflammatory Diseases

Studies explored the use of hydrocortisone in conditions characterized by fluctuating or episodic manifestations, such as certain autoimmune diseases. Research examined outcomes related to physical discomfort, like joint pain and swelling, and structural changes in joints. Findings describe patterns observed in the studies regarding short-term symptom scores and inflammation markers. Research provides insight, but data show patterns related to structural changes that require further context, as many studies included related corticosteroids (e.g., prednisone) rather than hydrocortisone specifically.

Key Studies & References

  1. Hydrocortisone for Adrenal Insufficiency (NIH Bookshelf)
  2. Hydrocortisone systemic (MedlinePlus Drug Information, Extended)

Frequently Asked Questions (FAQ)

Common questions about Hydrocortone (FAQ)

Q: Is Hydrocortone the same as topical hydrocortisone cream?

Hydrocortone is a brand name for systemic hydrocortisone, often supplied as tablets or injections. While the active ingredient, hydrocortisone, is the same substance used in topical creams, regulatory documents clarify that the systemic and localized forms have different approved uses and purposes. The tablets are taken internally, while the cream is applied to the skin for local action.

Q: How quickly can a person expect Hydrocortone to start working?

The time it takes for hydrocortisone to take effect depends on the route of administration. Official pharmacokinetic data indicates that when the medicine is administered intravenously (IV), effects may be seen within about one hour. For oral tablets, the peak concentration in the blood is typically reached in less than one hour.

Q: How long does Hydrocortone stay in your system after stopping it?

The official pharmacokinetic data indicates that the half-life of hydrocortisone is generally short, approximately 1.5 hours. This means it takes this long for half the drug to leave the system. Most of the administered dose is excreted from the body within 12 hours.

Q: Is Hydrocortone known to cause weight gain?

Yes, weight gain is noted as an adverse reaction in official product information. This is often associated with sodium retention, fluid accumulation, and increased appetite, which are also reported side effects. Discussed in official documents, these effects are typically dose-dependent.

Q: Are there any long-term side effects associated with Hydrocortone use?

Yes. Prolonged use of corticosteroids can cause long-term effects such as posterior subcapsular cataracts, glaucoma with possible damage to the optic nerves, osteoporosis, and suppression of the body's natural hormone production (HPA axis suppression).

Q: What are the signs of having too much Hydrocortone in your body?

Long-term use or use above the required physiological dose is associated with the potential to lead to a Cushingoid appearance. Signs can include a full or round face, weight gain in the upper back or belly, easy bruising, and abnormal fat deposits.

Q: Does Hydrocortone interact with common over-the-counter pain medications?

Official safety guidance indicates a caution regarding Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), which are common pain medications like ibuprofen. Taking Hydrocortone concurrently with NSAIDs increases the potential for serious gastrointestinal side effects, such as bleeding or ulceration.

Q: Can taking Hydrocortone affect the results of blood tests?

Yes. Official warnings state that medical tests may be required to check for unwanted effects, as hydrocortisone can affect parameters like blood glucose concentration and electrolyte levels (sodium and potassium).

Q: Is it safe to drink alcohol in moderation while taking Hydrocortone?

The official FDA label does not list alcohol as a formal, specific drug interaction. However, government safety guidance often advises against concurrent use of corticosteroids with alcohol and NSAIDs due to the documented potential for a combined increased risk of stomach bleeding.

Q: Is there a risk of interaction between Hydrocortone and birth control pills?

Yes. Estrogen and estrogen-containing products (like most combined birth control pills) may decrease the metabolism of hydrocortisone, potentially increasing the level of hydrocortisone in the blood and the risk of side effects. The regulatory label notes that dose adjustment may be necessary.

Q: What other prescription medications should be discussed with a doctor before starting Hydrocortone?

Regulatory documents note that medications that affect liver enzymes (CYP3A4 inducers or inhibitors), potassium-depleting agents, Antidiabetic agents, and drugs that increase the risk of gastrointestinal issues, such as NSAIDs, may need to be discussed.

Q: What happens if a dose of Hydrocortone is missed?

Official patient information describes that a dose may be taken as soon as possible, but if it is nearly time for the next dose, the missed dose is usually skipped. It is advised not to take double or extra doses.

Q: Is it necessary to carry a specific medical card or wear identification when taking Hydrocortone?

Yes. Official patient resources indicate that for prolonged use, carrying an identification card with medication details is often recommended. This is a precautionary measure to inform emergency personnel about the medication being taken.

Q: What is the difference between Hydrocortone and other corticosteroids like prednisone?

Official drug classification indicates that Hydrocortone (hydrocortisone) is a short-acting corticosteroid, and it is chemically identical to the body's natural cortisol. Other steroids, like prednisone, are classified as intermediate-acting and have a higher anti-inflammatory potency than hydrocortisone.

Q: Why do official documents mention 'stress doses' of Hydrocortone?

Stress dosing is mentioned because Hydrocortone can suppress the body’s ability to produce its own cortisol. During periods of physical stress (like surgery, fever, or severe illness), patients who are steroid-dependent may require a temporary supplemental dose to prevent a severe complication called an adrenal crisis.

Q: Are there different strengths of Hydrocortone tablets available?

The total daily dose of hydrocortisone tablets for adults varies widely, suggesting that the medication is available in different strengths to allow for dose adjustment based on the medical condition.

Q: Is it normal to feel more energetic or fatigued after starting Hydrocortone?

Official adverse reaction listings include fatigue, unusual weakness, and general malaise (discomfort) as potential side effects. Psychiatric changes, including mood swings, are also noted and may affect a person's perceived energy level.

Q: Are there any dietary restrictions generally recommended while taking Hydrocortone?

Yes. Because average and large doses can cause elevation of blood pressure, salt and water retention, and increased potassium excretion, dietary salt restriction and possibly potassium supplementation are noted as being potentially necessary. Grapefruit juice is also noted to increase the concentration of hydrocortisone in the body and should be avoided.

Q: Why is this medication not prescribed to everyone who has inflammation?

Official warnings state that the drug carries significant risks and is not for general use. These risks include the potential for serious or fatal infections due to immune system suppression, the risk of developing conditions like peptic ulcers or glaucoma, and the development of a Cushingoid state.

Q: Are there official guidelines for monitoring patients on long-term Hydrocortone therapy?

Yes. Official warnings state that regular medical visits are important to check for unwanted effects of long-term therapy. This monitoring often involves specific blood or urine tests and checks for potential complications such as cataracts, glaucoma, and osteoporosis.

Q: Is Hydrocortone known to cause bruising easily?

Yes, easy bruising (ecchymosis) is listed as an adverse effect in the official safety information. This finding is often associated with the long-term use of the medication, particularly in patients who exhibit other signs of the Cushingoid state.

Q: What are the official warnings about taking Hydrocortone with non-steroidal anti-inflammatory drugs (NSAIDs)?

The official warning advises that combining hydrocortisone with NSAIDs (like ibuprofen or naproxen) increases the risk of serious gastrointestinal side effects. These reactions include inflammation and bleeding, with the risk of ulceration or perforation.

Q: Can people with a history of stomach ulcers take Hydrocortone?

Regulatory documents indicate that caution is advised for patients with active or latent peptic ulcers. This is due to the documented risk of gastrointestinal complications, including perforation and hemorrhage.

Q: Do you get withdrawal symptoms if you stop taking Hydrocortone suddenly?

Yes, abruptly stopping the medication can lead to serious consequences, including a life-threatening adrenal crisis or what is sometimes referred to as 'steroid withdrawal syndrome.' The official label mandates that the dosage must be gradually reduced (tapered) to prevent this complication.

How should Hydrocortone be stored and disposed of?

How to Store and Dispose of Hydrocortisone

Hydrocortisone must be stored according to specific regulatory requirements to maintain its stability. The medication must be stored at controlled room temperature, typically between 20 C to 25 C (68 F to 77 F). It is a mandatory instruction to protect the product from freezing and store it away from excess moisture. All formulations must be kept in a tightly closed container and strictly out of the sight and reach of children.

Specific stability rules apply to certain preparations; for instance, the reconstituted injectable solution has a limited shelf-life and must be discarded after a few hours or a day, depending on the temperature. Expired or unused hydrocortisone must be disposed of in accordance with local regulations for pharmaceutical waste, and generally should not be thrown into household trash or wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hydrocortone found in:

A-Z Index: